Summary
Updated Aug 31, 2026
Elizabeth A. Grammer is Director of Sagimet Biosciences Inc. (SGMT). 6 SEC Form 4 filings on record going back to 2024, most recently on 15 June 2026. Most recent open-market trade: sold $33K of ARDX on 25 November 2025. Lifetime open-market sales: $126K.
Recent Transactions
4Every recent SEC Form 4 transaction Elizabeth A. Grammer has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Elizabeth A. Grammer files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- George Kemble - $4.22M of SGMT open-market activity in the last 12 months
- David Happel - $562K of SGMT open-market activity in the last 12 months
- Elizabeth Rozek - $96K of SGMT open-market activity in the last 12 months
- Eduardo Bruno Martins - $20K of SGMT open-market activity in the last 12 months
- Thierry Chauche - $7K of SGMT open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Elizabeth A. Grammer?
Elizabeth A. Grammer is a corporate insider, tracked as Director of Sagimet Biosciences Inc. (SGMT). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Elizabeth A. Grammer submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Elizabeth A. Grammer been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($126K) across all tracked filings.
Where can I see all of Elizabeth A. Grammer's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Elizabeth A. Grammer and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
